Minerva Neurosciences Inc (NERV)
2.55
-0.02
(-0.73%)
USD |
NASDAQ |
May 17, 16:00
2.55
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences Enterprise Value: -17.19M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -17.19M |
| May 16, 2024 | -16.85M |
| May 15, 2024 | -16.81M |
| May 14, 2024 | -17.47M |
| May 13, 2024 | -17.75M |
| May 10, 2024 | -18.10M |
| May 09, 2024 | -17.26M |
| May 08, 2024 | -17.26M |
| May 07, 2024 | -17.40M |
| May 06, 2024 | -18.45M |
| May 03, 2024 | -18.24M |
| May 02, 2024 | -18.38M |
| May 01, 2024 | -18.03M |
| April 30, 2024 | -18.31M |
| April 29, 2024 | -17.96M |
| April 26, 2024 | -17.78M |
| April 25, 2024 | -17.82M |
| April 24, 2024 | -17.19M |
| April 23, 2024 | -17.12M |
| April 22, 2024 | -16.99M |
| April 19, 2024 | -17.47M |
| April 18, 2024 | -17.33M |
| April 17, 2024 | -17.54M |
| April 16, 2024 | -17.33M |
| April 15, 2024 | -17.89M |
| Date | Value |
|---|---|
| April 12, 2024 | -17.33M |
| April 11, 2024 | -17.06M |
| April 10, 2024 | -17.54M |
| April 09, 2024 | -17.06M |
| April 08, 2024 | -17.06M |
| April 05, 2024 | -17.06M |
| April 04, 2024 | -17.12M |
| April 03, 2024 | -17.06M |
| April 02, 2024 | -17.23M |
| April 01, 2024 | -17.12M |
| March 28, 2024 | -22.87M |
| March 27, 2024 | -23.43M |
| March 26, 2024 | -22.94M |
| March 25, 2024 | -22.31M |
| March 22, 2024 | -22.24M |
| March 21, 2024 | -22.80M |
| March 20, 2024 | -22.03M |
| March 19, 2024 | -22.38M |
| March 18, 2024 | -22.03M |
| March 15, 2024 | -21.40M |
| March 14, 2024 | -21.68M |
| March 13, 2024 | -21.19M |
| March 12, 2024 | -21.54M |
| March 11, 2024 | -21.26M |
| March 08, 2024 | -21.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.53M
Minimum
Jun 22 2022
539.01M
Maximum
May 26 2020
56.32M
Average
9.466M
Median
Jul 27 2023
Enterprise Value Benchmarks
| Viking Therapeutics Inc | 6.425B |
| Janux Therapeutics Inc | 1.790B |
| ACADIA Pharmaceuticals Inc | 1.973B |
| CytomX Therapeutics Inc | -3.016M |
| Calidi Biotherapeutics Inc | 9.003M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.569M |
| Total Expenses (Quarterly) | 6.682M |
| EPS Diluted (Quarterly) | -1.13 |
| Earnings Yield | -177.8% |